To develop and test the effect of a patient-centered HIV prevention decision aid on HIV pre-exposure prophylaxis (PrEP) uptake among women with substance use disorders (SUD) in treatment.
To test the effect of the informed decision aid intervention on PrEP uptake among women with substance use disorders in treatment. Investigators hypothesize that compared to those receiving standard harm reduction information, women receiving the decision aid will have a significant increase in PrEP uptake at 6 and 12 months post-intervention.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
164
Participants in the experimental arm will receive the PrEP decision aid.
Standard harm reduction information
Yale AIDS Program
New Haven, Connecticut, United States
PrEP Uptake
PrEP uptake is measured by attending an appointment with a provider for the purposes of starting PrEP.
Time frame: 12 months
PrEP Adherence by Self Report
Adherence to PrEP is measured by pill count
Time frame: 12 months
PrEP Adherence by Pharmacy Refill
Adherence to PrEP is measured by pharmacy refill data
Time frame: 12 months
Changes in PrEP receptiveness
Receptiveness to PrEP (pre- and post- decision aid) is measured on a receptiveness scale (Likert 1-5)
Time frame: 12 months
Changes in HIV risk behaviors
Changes in HIV risk is measured by a modified risk assessment form from NIDA
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.